Wed, May 17, 2023
Tue, May 16, 2023
Mon, May 15, 2023
Fri, May 12, 2023

Evan David Seigerman Maintained (CADL) at Buy with Decreased Target to $3 on, May 15th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-3-on-may-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Evan David Seigerman of BMO Capital, Maintained "Candel Therapeutics, Inc." (CADL) at Buy with Decreased Target from $9 to $3 on, May 15th, 2023.

Evan has made no other calls on CADL in the last 4 months.



There is 1 other peer that has a rating on CADL. Out of the 1 peers that are also analyzing CADL, 0 agree with Evan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Evan


  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $7 on, Friday, March 31st, 2023

Publication Contributing Sources